Clinical Trials Browser

Has results × Adrenal Cortex Neoplasms × Axitinib × Clear all

NCT01255137 2013-06-27

Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-Pathway in Metastatic, Recurrent or Primary Unresectable Adrenocortical Cancer

Phase 2 Completed

13 enrolled 9 charts

Adrenal Cortex Neoplasms